Kodak reportedly under SEC investigation over disclosure of U.S. drug producing deal

(CNBC) The Securities and Exchange Commission is investigating Eastman Kodak’s disclosure about getting awarded a $765 million loan from the U.S. government to start producing drug ingredients, which sent the stock up on heavy volume ahead of the official announcement, The Wall Street Journal reported Tuesday. On July 27, a day before Kodak, as well as President Donald Trump, announced the deal to make ingredients in generic drugs in response to the coronavirus pandemic, shares of the film pioneer soared nearly 25% with trading volumes far exceeding those in previous sessions.

To read this article:

This entry was posted in Syndicated. Bookmark the permalink.

Leave a Reply